Conditions: Macular Edema Secondary to Branch Retinal Vein Occlusion
Keywords: BRVO macular edema vision impairment retinal vein occlusion ranibizumab branch retinal vein occlusion anti-VEGF therapy RFB002
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 283
Healthy volunteers: no

Brief summary:
Provided efficacy and safety data on intravitreal injections of ranibizumab 0.5 mg in patients with visual impairment due to macular edema secondary to BRVO

Detailed description:

Arms:
arm 1: PRN Intravitreal injection arm 2: As of Month 6 ranibizumab 0.5 mg PRN intravitreal injection

Interventions: intervention 1: Ranibizumab 0.5 mg intervention 2: Sham injection
Intervention descriptions: intervention 1: intravitreal injection of 0.05 ml intervention 2: Sham intravitreal injection

Protocol document: